UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue

Cancer, 2023-02, Vol.129 (4), p.634-642

2023

Volltextzugriff (PDF)

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing

The Journal of molecular diagnostics : JMD, 2017-09, Vol.19 (5), p.801-804

2017

Volltextzugriff (PDF)

Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung

Histopathology, 2021-03, Vol.78 (4), p.578-585

2021

Volltextzugriff (PDF)

Biomarkers for Homologous Recombination Deficiency in Cancer

Journal of personalized medicine, 2021-06, Vol.11 (7), p.612

2021

Volltextzugriff (PDF)

Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies

Modern pathology, 2019-05, Vol.32 (5), p.627-638

2019

Volltextzugriff (PDF)

Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors

The Journal of molecular diagnostics : JMD, 2019-11, Vol.21 (6), p.971-984

2019

Volltextzugriff (PDF)

Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation

BMC medical genomics, 2021-02, Vol.14 (1), p.62-14, Article 62

2021

Volltextzugriff (PDF)

Block Excision of Iridociliary Tumors Enables Molecular Profiling and Immune Vaccination

Ophthalmology (Rochester, Minn.), 2017-02, Vol.124 (2), p.268-270

2017

Volltextzugriff (PDF)

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors

BMC cancer, 2020-05, Vol.20 (1), p.408-408, Article 408

2020

Volltextzugriff (PDF)

Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Nature communications, 2018-11, Vol.9 (1), p.4655-4655, Article 4655

2018

Volltextzugriff (PDF)

First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors

Oncoimmunology, 2019-12, Vol.8 (12), p.e1665977-e1665977

2019

Volltextzugriff (PDF)

Expression Profiling of Extracellular Matrix Genes Reveals Global and Entity-Specific Characteristics in Adenoid Cystic, Mucoepidermoid and Salivary Duct Carcinomas

Cancers, 2020-08, Vol.12 (9), p.2466

2020

Volltextzugriff (PDF)

Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours

British journal of cancer, 2022-04, Vol.126 (6), p.937-947

2022

Volltextzugriff (PDF)

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

Cancer Immunology, Immunotherapy, 2020-04, Vol.69 (4), p.523-533

2020

Volltextzugriff (PDF)

Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors

Computational and structural biotechnology journal, 2019-01, Vol.17, p.1339-1347

2019

Volltextzugriff (PDF)

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Nature communications, 2018-11, Vol.9 (1), p.1-13

2018

Volltextzugriff (PDF)

Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy

NPJ precision oncology, 2021-06, Vol.5 (1), p.52-52, Article 52

2021

Volltextzugriff (PDF)

Targeted RNA-sequencing for the evaluation of gene fusions in lung tumors: current status and future prospects

Expert review of molecular diagnostics, 2021-06, Vol.21 (6), p.531-534

2021

Volltextzugriff (PDF)

The value of tumor mutational burden to select patients for immunotherapy

Expert review of anticancer therapy, 2021-01, Vol.21 (1), p.1-3

2021

Volltextzugriff (PDF)

Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy

Cancer Immunology, Immunotherapy, 2019-06, Vol.68 (6), p.973-982

2019

Volltextzugriff (PDF)

MP50-01 VALIDATION OF AGR2 AND KRT19 AS SPECIFIC PROTEINS BEING SIGNIFICANTLY AND DIFFERENTIALLY EXPRESSED IN TERATOMA COMPARED TO NECROSIS IN RETROPERITONEAL LYMPH NODE RESECTIONS AFTER CHEMOTHERAPY (PCRPLND)

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

Validation of AGR2 and KRT19 as specific proteins being significantly and differentially expressed in teratoma compared to necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.412-412

2023

Volltextzugriff (PDF)

Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.408-408

2022

Volltextzugriff (PDF)

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition

Journal of thoracic oncology, 2024-01, Vol.19 (1), p.160-165

2024

Volltextzugriff (PDF)

KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.1550-1567

2023

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(26)
Oncology
(15)
Humans
(12)
Tumors
(10)
Mutation
(9)
Lung Cancer
(8)
Pathology
(7)
Lung Neoplasms - Genetics
(6)
Patients
(6)
Female
(5)
Immunotherapy
(5)
Male
(5)
Medicine
(5)
Medicine & Public Health
(5)
Cancer
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Carcinoma, Non-Small-Cell Lung - Genetics
(4)
Carcinoma, Non-Small-Cell Lung - Pathology
(4)
Deoxyribonucleic Acid
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing

Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung

Biomarkers for Homologous Recombination Deficiency in Cancer

Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies

Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors

Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation

Block Excision of Iridociliary Tumors Enables Molecular Profiling and Immune Vaccination

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors

Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors

Expression Profiling of Extracellular Matrix Genes Reveals Global and Entity-Specific Characteristics in Adenoid Cystic, Mucoepidermoid and Salivary Duct Carcinomas

Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy

Targeted RNA-sequencing for the evaluation of gene fusions in lung tumors: current status and future prospects

The value of tumor mutational burden to select patients for immunotherapy

Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy

MP50-01 VALIDATION OF AGR2 AND KRT19 AS SPECIFIC PROTEINS BEING SIGNIFICANTLY AND DIFFERENTIALLY EXPRESSED IN TERATOMA COMPARED TO NECROSIS IN RETROPERITONEAL LYMPH NODE RESECTIONS AFTER CHEMOTHERAPY (PCRPLND)

Validation of AGR2 and KRT19 as specific proteins being significantly and differentially expressed in teratoma compared to necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND)

Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND)

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition

KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC

Suchergebnisse filtern